SciSparc Ltd. Ordinary Shares
SPRC
SPRC: SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company operates in the single segment of the Development of drugs based on cannabinoid molecules to be approved by an official regulatory authority.
moreShow SPRC Financials
Recent trades of SPRC by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by SPRC's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Compositions and methods of potentiating antimicrobials Nov. 08, 2022
-
Patent Title: Combination of cannabinoids and n-acylethanolamines Feb. 01, 2022
-
Patent Title: Combinations of cannabinoids and n-acylethanolamines Dec. 28, 2021
-
Patent Title: Combinations of cannabinoids and n-acylethanolamines Dec. 14, 2021
Federal grants, loans, and purchases
Followers on SPRC's company Twitter account
Number of mentions of SPRC in WallStreetBets Daily Discussion
Recent insights relating to SPRC
Recent picks made for SPRC stock on CNBC
ETFs with the largest estimated holdings in SPRC
Flights by private jets registered to SPRC